Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases

Research output: Contribution to journalArticlepeer-review

Abstract

In the present study, we hypothesized that endotoxemia produces metalloendopeptidase (MEPD)-dependent generation of endothelin-1 (ET-1) and alters NOS expression correlating with p38-mitogen-activated protein kinase (MAPK) phosphorylation in thoracic aorta. Male Sprague-Dawley rats (350-400 g) were subjected to two groups randomly; sham-treated (N = 10) and lipopolysaccharide (LPS)-treated (N = 10) (E. coli LPS 2 mg/kg bolus + 2 mg/kg infusion for 30 min). The animals in each group were further subdivided into vehicle and MEPD inhibitor phosphoramidon (1 mg/kg bolus, PHOS)-treated groups. LPS produces a significant decrease in mean arterial pressure (MAP) at 2 h post endotoxemia that was blocked by PHOS. PHOS attenuated LPS-induced increase in tumor necrosis factor-alpha (TNF-α) concentration at 2- and 24 h post-LPS administration. LPS significantly elevated plasma concentrations of ET-1 at 2- and 24 h post endotoxemia. An upregulated preproET-1 expression following both LPS and MEPD inhibition was observed in thoracic aorta at 2 h post treatment. PHOS effectively blocked conversion of preproET-1 to ET-1 in thoracic aorta locally at 24 h post treatment in endotoxic rats. PHOS inhibited LPS-induced upregulation of inducible NOS (iNOS), downregulation of endothelial NOS (eNOS) and elevation of NO byproducts (NO x) in thoracic aorta. PHOS also blocked LPS-induced upregulated p38-MAPK phosphorylation in thoracic aorta at 24 h post endotoxemia. The data revealed that LPS induces MEPD-sensitive inflammatory response syndrome (SIRS) at 2- and 24 h post endotoxemia. We concluded that inhibition of MEPD not only decreases the levels of ET-1 but also simultaneously downregulates protein expression of iNOS and phosphorylated p38-MAPK while increasing eNOS in thoracic aorta during SIRS in endotoxemia. We suggest that MEPD-dependent ET-1 and NO mechanisms may be involved in endotoxemia-induced altered p38-MAPK phosphorylation. © 2004 Kluwer Academic Publishers.

Original languageAmerican English
JournalMolecular and cellular biochemistry
Volume265
StatePublished - Jan 1 2004

Keywords

  • Animalia
  • Animals
  • Aorta
  • Biological
  • Cytokine
  • Cytokines
  • Endothelin
  • Endothelin-1
  • Glycopeptides
  • Lipopolysaccharide
  • Lipopolysaccharides
  • Metalloendopeptidases
  • Models
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos2 protein
  • Nos3 protein
  • Rats
  • Signaling
  • Sprague Dawley rat
  • Sprague-Dawley
  • Systemic hemodynamic
  • TNF-α
  • Thoracic
  • Time Factors
  • Up-Regulation
  • animal
  • animal tissue
  • article
  • biological model
  • biosynthesis
  • blood pressure
  • chemistry
  • clinical trial
  • controlled clinical trial
  • controlled study
  • drug effect
  • drug inhibition
  • drug mechanism
  • endothelial nitric oxide synthase
  • endothelin 1
  • endothelium cell
  • endotoxemia
  • enzyme activity
  • enzyme phosphorylation
  • enzymology
  • glycopeptide
  • hemodynamics
  • immunoblotting
  • inducible nitric oxide synthase
  • inflammation
  • male
  • mean arterial pressure
  • metabolism
  • metalloproteinase
  • metalloproteinase inhibitor
  • mitogen activated protein kinase p38
  • nitric oxide
  • nitric oxide synthase
  • nonhuman
  • p38 Mitogen-Activated Protein Kinases
  • pathology
  • phosphoramidon
  • phosphorylation
  • protein expression
  • protein synthesis
  • randomized controlled trial
  • rat
  • regulatory mechanism
  • signal transduction
  • thoracic aorta
  • time
  • tumor necrosis factor alpha
  • upregulation

Disciplines

  • Life Sciences

Cite this